(RTTNews) - Roche (RHHBY) announced the launch of the Elecsys Anti-p53 immunoassay for the in vitro quantitative determination of anti-p53 antibodies. The test is used to aid physicians to diagnose ...
Anti-p53 antibodies are antibodies that mistakenly target a patient's own tissues, leading to a growth of solid tumors. Screening for Anti-p53 helps to diagnose throat, bowel and breast cancers ...
(RTTNews) - The U.S. Food and Drug Administration has granted breakthrough device designation for Roche's (RHHBY) Elecsys growth differentiation factor-15 or GDF-15 assay to help identify patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback